Ładuje się......
High expression of interleukin-enhancer binding factor 3 predicts poor prognosis in patients with lung adenocarcinoma
Interleukin-enhancer binding factor 3 (ILF3) is a double-stranded RNA-binding protein that has been reported to contribute to the occurrence and progression of various malignant tumors. The aim of the present study was to evaluate the prognostic value of ILF3 and to apply this knowledge to avoid exc...
Zapisane w:
| Wydane w: | Oncol Lett |
|---|---|
| Główni autorzy: | , , , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
D.A. Spandidos
2020
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7039148/ https://ncbi.nlm.nih.gov/pubmed/32194712 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.11330 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|